ENGENE HOLDINGS INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.14 USD | -0.61% |
|
+1.23% | +42.36% |
| May. 15 | EnGene Holdings Inc. Approves Board Appointments | CI |
| Apr. 22 | Wells Fargo Starts enGene Holdings With Overweight Rating, $30 Price Target | MT |
Valuation
| Fiscal Period: October | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | - | 567.1 | - | - |
| Enterprise Value (EV) 1 | - | 334.6 | 225.5 | 295.1 |
| P/E ratio | -0.14 x | -9.73 x | -8.79 x | -8.44 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | - | - | 22.2 x |
| EV / Revenue | - | - | - | 11.6 x |
| EV / EBITDA | - | -7.47 x | -3.39 x | -3.62 x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | - | 2.36 x | 1.87 x | 2.73 x |
| Nbr of stocks (in thousands) | - | 44,101 | - | - |
| Reference price 2 | 21.70 | 12.86 | 12.86 | 12.86 |
| Announcement Date | 1/29/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: October | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | - | - | - | 25.51 |
| EBITDA 1 | - | -44.81 | -66.47 | -81.63 |
| EBIT 1 | - | -50.87 | -72.71 | -83.19 |
| Operating Margin | - | - | - | -326.15% |
| Earnings before Tax (EBT) 1 | - | -54.13 | -79.07 | -89.51 |
| Net income 1 | -99.92 | -54.09 | -71.1 | -78.71 |
| Net margin | - | - | - | -308.6% |
| EPS 2 | -151.2 | -1.322 | -1.463 | -1.523 |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Announcement Date | 1/29/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: Oktober | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - |
| EBITDA 1 | - | -6.515 | -9.095 | -12.76 | - | - |
| EBIT 1 | - | -10.95 | -13.97 | -17.53 | -20.8 | -21.8 |
| Operating Margin | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | - | -13.45 | -16.1 | -19.65 | -20.7 | -21.7 |
| Net income 1 | - | -13.45 | -16.05 | -19.6 | -20.6 | -21.7 |
| Net margin | - | - | - | - | - | - |
| EPS 2 | -0.4600 | -0.2731 | -0.2928 | -0.3545 | -0.6700 | -0.6900 |
| Dividend per Share 2 | - | - | - | - | - | - |
| Announcement Date | 3/11/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: Oktober | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | - | 233 | 342 | 272 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | - | -26.1% | -19.7% | -31.7% |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share 2 | - | 5.460 | 6.890 | 4.710 |
| Cash Flow per Share | - | - | - | - |
| Capex 1 | - | 0.51 | 0.51 | 0.51 |
| Capex / Sales | - | - | - | 1.98% |
| Announcement Date | 1/29/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
12.86
USD
Average target price
34.4
USD
Spread / Average Target
+167.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +42.36% | 567M | |
| +67.53% | 63.85B | |
| -0.77% | 41.83B | |
| +45.66% | 40.65B | |
| -10.72% | 27.12B | |
| +13.30% | 26.52B | |
| -22.79% | 18.69B | |
| +4.70% | 12.73B | |
| +24.10% | 12.11B | |
| +27.41% | 12.07B |
- Stock Market
- Equities
- ENGN Stock
- Financials enGene Holdings Inc.
